Peak Bone Mass in Young HIV-Infected Patients Compared With Healthy Controls
- 1 February 2014
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 65 (2), 207-212
- https://doi.org/10.1097/01.qai.0000435598.20104.d6
Abstract
Peak bone mass (PBM) is the amount of bone present at the end of skeletal maturation. It is an important determinant of osteoporotic fracture risk. Data on the PBM in the HIV-infected population are lacking. We performed a multicenter (6 centers in Spain), case-control study to assess PBM using dual-energy x-ray absorptiometry. We studied HIV-infected patients aged 20-30 years and compared them with age- and gender-matched non-HIV-infected controls. We also assessed the predictive factors for a low PBM. We included 307 subjects: 232 HIV-infected patients and 75 non-HIV-infected controls. Bone mineral density was similar in both groups although differences were seen in the total femur T-score (-0.15SD versus +0.50SD, respectively, P = 0.018). The percentage of osteopenia and osteoporosis was higher in the HIV-infected patients (56.5% and 10.7%, respectively) than in the controls (50.7% and 4%, respectively; P = 0.019). Osteoporosis was more frequent in HIV-infected men than in control men and HIV-infected women (12.2% versus 5.5% and 4.8%, P = 0.033). Protease inhibitors and nadir CD4 T-cells were negatively associated with PBM, whereas fat and lean mass were positively associated with PBM. Bone mineral density was similar between HIV-infected patients aged 20-30 years than in age- and gender-matched controls. However, lower femoral T-scores and higher rate of osteopenia and osteoporosis were seen in HIV-infected men. Therapy with protease inhibitors, nadir CD4 counts, and fat and lean mass were predictive factors of PBM. Given that these patients will be living with HIV infection for many years, every effort should be made to modify risk factors.Keywords
This publication has 34 references indexed in Scilit:
- Osteoporosis in young adults: pathophysiology, diagnosis, and managementOsteoporosis International, 2012
- Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agentsAIDS, 2012
- High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort studyAIDS, 2010
- Loss of Bone Mineral Density After Antiretroviral Therapy Initiation, Independent of Antiretroviral RegimenJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic reviewAIDS, 2006
- Bone Mineral Density of the Lumbar Spine in White Mediterranean Spanish Children and Adolescents: Changes Related to Age, Sex, and PubertyPediatric Research, 1994
- Peak bone massOsteoporosis International, 1994
- Predictors of axial and peripheral bone mineral density in healthy children and adolescents, with special attention to the role of pubertyThe Journal of Pediatrics, 1993
- Heritable and life-style determinants of bone mineral densityJournal of Bone and Mineral Research, 1993
- Reduced Bone Mass in Daughters of Women with OsteoporosisNew England Journal of Medicine, 1989